From FierceAnimalHealth: Last June, the National Academies’ Institute of Medicine (IOM) hosted a two-day workshop in Washington, DC, aimed at promoting clinical research in dogs that can be translated to finding new cures for people. Now the IOM is sharing insights that came from the more than 20 veterinarians and scientists who attended the event.

One of the questions the workshop attendees pondered is whether there is sufficient understanding of the utility of comparative oncology in drug development. Everyone agreed that such studies must offer benefits for both the human and animal health community. “Although it is not the primary intent of comparative oncology research to lead to approval of a veterinary product, the data gained can effectively lead to such an outcome,” the authors note.

Read more here.